pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Aug 19·1 min read
save

Anthropic’s Claude AI designs miniproteins from scratch in new study

Aug 19, 2026·read at Endpoints ↗Neutral

Anthropic announced that its AI system Claude was used to design and generate miniproteins from scratch in a recent research campaign.

The study showed Claude could propose novel protein sequences, creating a library of miniproteins without relying on existing templates.

Anthropic highlighted the potential of AI‑driven protein design for future life‑science applications, while noting that broader implications remain to be evaluated.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Analysis: What Anthropic's protein study says about its life sciences aims”

read at Endpoints ↗
94 words · retrieved Aug 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 13h agoUnited Therapeutics' legal victory; BMS' Camzyos approved for kidsEndpoints
  • 13h agoIs AI jacking up healthcare costs?Endpoints
  • 14h agoLilly pulls back from Foghorn's synthetic lethality work as biotech sheds 40% of staffEndpoints
  • 15h ago#EASD26: Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapyEndpoints
  • 15h agoQ&A: Anthropic's life sciences team talk Claude's first scientific discoveryEndpoints